232 related articles for article (PubMed ID: 11704653)
1. Effects of cannabinoids on adrenaline release from adrenal medullary cells.
Niederhoffer N; Hansen HH; Fernandez-Ruiz JJ; Szabo B
Br J Pharmacol; 2001 Nov; 134(6):1319-27. PubMed ID: 11704653
[TBL] [Abstract][Full Text] [Related]
2. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
Niederhoffer N; Szabo B
Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
Niederhoffer N; Szabo B
J Pharmacol Exp Ther; 2000 Aug; 294(2):707-13. PubMed ID: 10900251
[TBL] [Abstract][Full Text] [Related]
4. Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart.
Szabo B; Nordheim U; Niederhoffer N
J Pharmacol Exp Ther; 2001 May; 297(2):819-26. PubMed ID: 11303075
[TBL] [Abstract][Full Text] [Related]
5. The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression.
Niederhoffer N; Schmid K; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):434-43. PubMed ID: 12709782
[TBL] [Abstract][Full Text] [Related]
6. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
[TBL] [Abstract][Full Text] [Related]
7. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
Pfitzer T; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2.
Song ZH; Slowey CA
J Pharmacol Exp Ther; 2000 Jan; 292(1):136-9. PubMed ID: 10604940
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Ross RA; Brockie HC; Fernando SR; Saha B; Razdan RK; Pertwee RG
Br J Pharmacol; 1998 Nov; 125(6):1345-51. PubMed ID: 9863666
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
Kathmann M; Weber B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
Ihenetu K; Molleman A; Parsons ME; Whelan CJ
Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
[TBL] [Abstract][Full Text] [Related]
12. Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats.
Pfitzer T; Niederhoffer N; Szabo B
Br J Pharmacol; 2004 Jul; 142(6):943-52. PubMed ID: 15226190
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
Szabo B; Siemes S; Wallmichrath I
Eur J Neurosci; 2002 Jun; 15(12):2057-61. PubMed ID: 12099913
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the respiratory effects of cannabinoids in rats.
Schmid K; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):301-8. PubMed ID: 13680088
[TBL] [Abstract][Full Text] [Related]
15. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro.
Szabo B; Müller T; Koch H
J Neurochem; 1999 Sep; 73(3):1084-9. PubMed ID: 10461898
[TBL] [Abstract][Full Text] [Related]
16. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
Gifford AN; Samiian L; Gatley SJ; Ashby CR
Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770
[TBL] [Abstract][Full Text] [Related]
17. Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [(3)H]CP55940 and [(3)H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release.
Dhopeshwarkar AS; Nicholson RA
Eur J Pharmacol; 2014 Jan; 723():431-41. PubMed ID: 24211785
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
Coutts AA; Pertwee RG
Br J Pharmacol; 1997 Aug; 121(8):1557-66. PubMed ID: 9283688
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
Ihenetu K; Molleman A; Parsons M; Whelan C
Eur J Pharmacol; 2003 Mar; 464(2-3):207-15. PubMed ID: 12620515
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
Terranova JP; Michaud JC; Le Fur G; Soubrié P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
